Title: Development of Compact CRISPR Editors for Multiplexed Editing of Complex Gene Networks Abstract The ability to perform multiplexed editing of the genome will provide significant opportunity to investigate into the interplay of various elements in the complex gene network. Since its advent, the CRISPR-Cas system has demonstrated unique advantages over previous genomic editing tools such as sequence specificity, programmability, and the ease of implementation. However, the utility of the existing non-nuclease CRISPR editors is still hampered by major challenges including limited ability of multiplexing and inefficient intracellular delivery. In this proposal, we aim to develop a new class of compact, multiplexable CRISPR editors that allow the genomic editing at transcriptional, epigenetic, and post-translational levels. At the center of these CRISPR editors are intracellularly evolved RNA aptamers that are capable of recruiting endogenous effectors independent of additional labeling and tagging, thereby enabling the locus-specific co-localization of the CRISPR editors and the endogenous effectors. CRISPR-based constructs will be developed to enable the intracellular selection of aptamers in both bacterial and mammalian cells for robust and highly specific recognition of various effectors regulating distinct cellular functions. We will further implement this technology into the multiplexable interrogation and manipulation of multiple distinct cellular functions including transcriptional activation, epigenetic remodeling, and DNA nucleobase editing. Compared to the existing CRISPR editors, the new CRISPR editors developed in this proposal do not require the delivery of exogenous effectors, allowing for the encoding gene to be efficiently delivered by a single adeno-associated virus (AAV) vector. These CRIPSR editors will be applied to executing multiplexed editing programs in genome-scale screens to identify novel genetic elements responsible for the emergence of drug resistance in cancer. If successful, the tools developed in this proposal can significantly improve our ability to understand and engineer the gene network in various applications spanning fundamental research and therapeutics.

Public Health Relevance

Although significant advances have been made in studying various genetic factors associated with disease, it still remains challenging to understand the interplay of these factors that leads to the onset and development of disease, an obstacle that is in part resulted from the lack of tools to systematically probe the complex interactions of different genes over the course of gene expression. We propose to address this problem by developing a new generation of compact genomic editors that can be delivered efficiently into the cells and recruit native cellular regulatory proteins to a user-defined site of the genome and repurpose them to regulate the expression of the local genes. If successful, this project will provide powerful tools that can coordinate multiple cellular proteins to simultaneously regulate the expression of multiple genes, thereby improving our understanding on how different genes interact in a complex gene network in disease development.

National Institute of Health (NIH)
National Human Genome Research Institute (NHGRI)
NIH Director’s New Innovator Awards (DP2)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Sofia, Heidi J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Boston College
Schools of Arts and Sciences
Chestnut Hill
United States
Zip Code